Literature DB >> 17586541

Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock.

Holger Thiele1, Richard W Smalling, Gerhard C Schuler.   

Abstract

Cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction (AMI). In addition to percutaneous coronary intervention, inotropes, and fluids, intraaortic balloon pumping (IABP) is most widely used for initial haemodynamic stabilization. However, the main limitation of IABP is the lack of active circulatory support and the requirement of a certain level of left ventricular (LV) function. In many patients with severe depression of LV function, haemodynamic support and LV unloading derived from IABP is insufficient to reverse CS. The use of percutaneous LV assist devices (LVAD) with active circulatory support might be beneficial in CS patients not responding to standard treatment including IABP support. This review reports the current experience of percutaneous LVAD in CS complicating AMI.

Entities:  

Mesh:

Year:  2007        PMID: 17586541     DOI: 10.1093/eurheartj/ehm191

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Treatment strategies for patients with an INTERMACS I profile.

Authors:  Walid K Abu Saleh; Odeaa Al Jabbari; Ashrith Guha; Matthias Loebe; Brian A Bruckner
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jan-Mar

2.  Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.

Authors:  K D Sjauw; A E Engström; M M Vis; W Boom; J Baan; R J de Winter; J G P Tijssen; J J Piek; J P S Henriques
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

3.  Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge® Registry.

Authors:  Maryna Masyuk; Peter Abel; Martin Hug; Bernhard Wernly; Assad Haneya; Stefan Sack; Konstantinos Sideris; Nicolas Langwieser; Tobias Graf; Georg Fuernau; Marcus Franz; Ralf Westenfeld; Malte Kelm; Stephan B Felix; Christian Jung
Journal:  Clin Res Cardiol       Date:  2019-04-26       Impact factor: 5.460

Review 4.  Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention.

Authors:  Bhuvnesh Aggarwal; Wahaj Aman; Omar Jeroudi; Neal S Kleiman
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jan-Mar

Review 5.  Physiological Implications of Myocardial Scar Structure.

Authors:  William J Richardson; Samantha A Clarke; T Alexander Quinn; Jeffrey W Holmes
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

Review 6.  Heart failure after myocardial infarction: clinical implications and treatment.

Authors:  Marcos F Minicucci; Paula S Azevedo; Bertha F Polegato; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Clin Cardiol       Date:  2011-06-17       Impact factor: 2.882

Review 7.  Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention.

Authors:  Jon Spiro; Sagar N Doshi
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

8.  Treatment of left main shock syndrome with percutaneous coronary intervention in the absence of an advanced left ventricular assist device or ECMO.

Authors:  Mutlu Vural; İrfan Şahin; İlker Avcı; Fatih Kızkapan; Sezai Yıldız
Journal:  Anatol J Cardiol       Date:  2015-05-22       Impact factor: 1.596

Review 9.  Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock.

Authors:  Zhao-Peng Zhong; Hong Wang; Xiao-Tong Hou
Journal:  Biomed Res Int       Date:  2016-05-16       Impact factor: 3.411

10.  Diagnosis and management of acute heart failure.

Authors:  Dilek Ural; Yüksel Çavuşoğlu; Mehmet Eren; Kurtuluş Karaüzüm; Ahmet Temizhan; Mehmet Birhan Yılmaz; Mehdi Zoghi; Kumudha Ramassubu; Biykem Bozkurt
Journal:  Anatol J Cardiol       Date:  2015-11       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.